Community references organize stack-related symptoms into rough severity tiers: Discontinue immediately: Severe abdominal pain radiating to the back (possible pancreatitis) Right-upper-quadrant pain after meals (possible gallbladder) Persistent dysesthesia at any dose Cardiac symptoms (chest pain, palpitations) Acute jaundice or dark urine Pause and evaluate: Vomiting more than 5-7 days at the same dose without titration improvement New persistent fatigue beyond expected GLP-1 fatigue Unexpected lab changes (transaminases, lipase, glucose) Weight loss outside the expected curve (sudden acceleration may indicate inadequate caloric intake) Continue with monitoring: Mild injection-site reaction Standard titration nausea that resolves at each stable step Standard appetite suppression Mild constipation (manageable with hydration and fiber) This is a community-described framework, not a clinical guideline
JNK, c-Jun N-terminal Kinase
There are currently no randomized, controlled clinical trials examining the effects of BPC-157 in humans
Nexe-Larsen CC, Srensen PH, Hausner H, Agersnap M, Baekdal M, Brnden A, Gustafsson LN, Sonne DP, Vedtofte L, Vilsbll T
be clear on your intentions
For the vast majority of people, yes